BPC-157 (Body Protective Compound), derived from a natural stomach protein, BPC-157 brings
Enhanced Immune Support
Consistent with our previous findings, theaflavins upregulated the expression of SLC3A2 protein in primary hepatocytes overexpressing HO-1, while downregulating the expression of ACSL4, SLC7A11, and GPX4 (Fig
DRG are enclosed within the dural sac, 15 albeit at a uniquely permeable site of the blood-brain barrier
10.1016/j.scitotenv.2022.155017 34 HuangI
available only through 503A compounding pharmacies under physician supervision Typical research dose range / 200-800 mcg/day subcutaneously, cycled 4-8 weeks Known lethal dose (LD50) / Not established in any species studied to date Rodent acute toxicity ceiling / No mortality observed at doses exceeding 10 mg/kg intraperitoneally Most reported excess-dose symptoms / Nausea, lightheadedness, flushing, injection-site irritation Organ toxicity at supratherapeutic doses / Not demonstrated in published preclinical literature Antidote availability / No specific antidote exists